The global hospital acquired infections therapeutic market was valued at USD 10.45 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 2.3 % during the forecast period. In this environment of modest expansion, regional manufacturing trends and cross‑border supply chains are increasingly influencing how therapeutic players execute market penetration strategies...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek